Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver diseaseXinrong Zhang, Vincent Wai‐Sun Wong, Jimmy Che‐To Lai et al.|Hepatology|2021Cited by 91
Risk of liver‐related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver diseaseXinrong Zhang, Vincent Wai‐Sun Wong, Henry Lik‐Yuen Chan et al.|Hepatology|2022Cited by 54
Age and the relative importance of liver‐related deaths in nonalcoholic fatty liver diseaseHuapeng Lin, Vincent Wai‐Sun Wong, Henry Lik‐Yuen Chan et al.|Hepatology|2022Cited by 50
U-shaped relationship between urea level and hepatic decompensation in chronic liver diseasesHuapeng Lin, Vincent Wai‐Sun Wong, Henry Lik‐Yuen Chan et al.|Clinical and Molecular Hepatology|2021Cited by 41
Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: A landmark analysisXinrong Zhang, Vincent Wai‐Sun Wong, Terry Cheuk‐Fung Yip et al.|Hepatology|2023Cited by 29